open access
An optimized long QT syndrome differentiating protocol: A new indication for wearable cardioverter-defibrillator vests


- Department of Cardiology, Pomeranian Medical University, Szczecin, Poland
open access
Abstract
Abstract


Title
An optimized long QT syndrome differentiating protocol: A new indication for wearable cardioverter-defibrillator vests
Journal
Kardiologia Polska (Polish Heart Journal)
Issue
Article type
Clinical vignette
Published online
2022-06-07
Page views
58
Article views/downloads
56
DOI
10.33963/KP.a2022.0142
Pubmed
Authors
Marcin Pilawa
Jarosław Kaźmierczak
Radosław Marek Kiedrowicz


- Priori SG, Blomström-Lundqvist C, Mazzanti A, et al. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J. 2015; 36(41): 2793–2867.
- Wallace E, Howard L, Liu M, et al. Long QT syndrome: genetics and future perspective. Pediatr Cardiol. 2019; 40(7): 1419–1430.
- Sasaoka S, Matsui T, Hane Y, et al. Time-to-Onset analysis of drug-induced long QT syndrome based on a spontaneous reporting system for adverse drug events. PLoS One. 2016; 11(10): e0164309.
- Sandhu U, Rajyaguru C, Cheung CC, et al. The wearable cardioverter-defibrillator vest: Indications and ongoing questions. Prog Cardiovasc Dis. 2019; 62(3): 256–264.
- Sterliński M, Oręziak A, Przybylski A, et al. Experts of the Heart Rhythm Section of the Polish Cardiac Society: opinion on the use of wearable cardioverter-defibrillators in Poland. Kardiol Pol. 2019; 77(2): 238–243.